Centre for Pharmaceutical Innovation (CPI), University of South Australia, Australia; College of Health Sciences, Addis Ababa University, Ethiopia.
Centre for Pharmaceutical Innovation (CPI), University of South Australia, Australia.
Int J Pharm. 2022 Nov 25;628:122324. doi: 10.1016/j.ijpharm.2022.122324. Epub 2022 Oct 22.
Despite being an effective therapy for menopausal symptoms, the use of oral estrogen is associated with low bioavailability and serious adverse effects of venous thromboembolism. Individualized therapy has been recommended to maximize benefits and curb the adverse effects, but much has not been done in developing formulations that offer flexibility to personalize therapy. In the present study, we employed an innovative 3D printing technology to design and develop bi-layered estradiol film with different infill patterns with an aim of improving bioavailability and facilitating personalized treatment. Hydroxypropyl cellulose (HPC-H) based formulation exhibited suitable rheological properties and was used as a feedstock to fabricate estradiol films with different infill patterns namely honeycomb, rectangular and plain. The back layer was prepared from a hydroxyethyl cellulose-based formulation. The resulting films were subsequently characterized in terms of their physicochemical, mechanical, environmental impact, and release characteristics among others. Films with a plain infill pattern exhibited significantly higher % elongation break and tensile strength. The in vitro drug release study revealed the fastest drug release profile for rectangular infill (96 % within 4 h) and the slowest drug release was observed for the plain infill pattern (∼35 % within 4 h), highlighting the effect of the infill pattern on release kinetics. Films with honeycomb infill patterns were selected for further characterization based on mechanical and in vitro release properties. No interaction between components of the formulation was observed and the absence of crystallinity in the final product was confirmed by Differential Scanning Calorimetry (DSC) and X-Ray Powder Diffraction analyses (XRD). The force of adhesiveness for the film was 0.13 ± 0.03 N. The predicted AUC 0-4 h, C, and T were 144.85 ng·h/mL, 65.97 ng/mL, and 0.83 h for a film (honeycomb infill pattern) loaded with 1 mg of estradiol. The printing process of films with honeycomb and rectangular infill patterns was evaluated as "green" using the index of Greenness Assessment of Printed Pharmaceuticals (iGAPP) tool. Our finding demonstrates the development of bi-layered estradiol film using Pressure assisted microsyringe (PAM) 3D printing and the influence of infill patterns on release kinetics and mechanical properties. The fabricated film not only facilitates the move towards personalized medicine but could also improve the bioavailability of the drugs by bypassing the hepatic first-pass metabolism and decreasing wash-out by the saliva.
尽管口服雌激素是治疗更年期症状的有效方法,但它的生物利用度低,且与静脉血栓栓塞等严重不良反应相关。为了使治疗获益最大化并控制不良反应,已经推荐采用个体化治疗,但在开发具有个体化治疗灵活性的制剂方面进展甚微。在本研究中,我们采用创新的 3D 打印技术设计并开发了具有不同填充图案的双层雌二醇薄膜,旨在提高生物利用度并促进个体化治疗。基于羟丙基纤维素(HPC-H)的配方表现出合适的流变性能,并被用作制备具有不同填充图案(例如蜂窝状、矩形和平坦)的雌二醇薄膜的原料。背面由基于羟乙基纤维素的配方制备。随后对所得薄膜进行了物理化学、机械、环境影响和释放特性等方面的表征。具有平坦填充图案的薄膜表现出明显更高的断裂伸长率和拉伸强度。体外药物释放研究表明,矩形填充的药物释放最快(4 小时内释放 96%),而平坦填充的药物释放最慢(4 小时内释放约 35%),突出了填充图案对释放动力学的影响。基于机械和体外释放性能,选择具有蜂窝填充图案的薄膜进行进一步表征。制剂成分之间未观察到相互作用,差示扫描量热法(DSC)和 X 射线粉末衍射分析(XRD)证实最终产物无结晶度。薄膜的粘合力为 0.13±0.03N。加载 1mg 雌二醇的薄膜(蜂窝填充图案)的 AUC 0-4h、C 和 T 预测值分别为 144.85ng·h/mL、65.97ng/mL 和 0.83h。使用印刷药物绿色度评估指数(iGAPP)工具评估具有蜂窝状和矩形填充图案的薄膜的打印过程为“绿色”。我们的研究结果表明,使用压力辅助微量注射器(PAM)3D 打印开发了双层雌二醇薄膜,并研究了填充图案对释放动力学和机械性能的影响。所制备的薄膜不仅有利于向个体化医学发展,还可以通过绕过肝脏首过代谢和减少唾液冲洗来提高药物的生物利用度。